These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Lipodystrophy and women: a beach ball on sticks. Marcotte B Posit Aware; 2004; 15(3):14-6. PubMed ID: 15206387 [No Abstract] [Full Text] [Related]
10. Protease inhibitors in HIV infection. Lipodystrophy may be a consequence of prolonged survival. Buss N; Duff F BMJ; 1999 Jan; 318(7176):122. PubMed ID: 9880292 [No Abstract] [Full Text] [Related]
11. Toxicity of antiretroviral therapy and implications for drug development. Carr A Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812 [No Abstract] [Full Text] [Related]
15. The latest word on lipodystrophy and mitochondrial toxicity (and old words that still resound). Mascolini M IAPAC Mon; 2002 Jan; 8(1):14-32. PubMed ID: 11858198 [No Abstract] [Full Text] [Related]
17. Adverse drug reactions to protease inhibitors. Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251 [TBL] [Abstract][Full Text] [Related]
18. Substitution for protease inhibitors in HIV therapy. Mikhail E N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14689602 [No Abstract] [Full Text] [Related]
19. [Facial lipodystrophy in patients with HIV infections troublesome to treat]. Walther RA Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of HIV-associated lipodystrophy. Wanke C AIDS Clin Care; 2000 Dec; 12(12):100. PubMed ID: 12211161 [No Abstract] [Full Text] [Related] [Next] [New Search]